InvestorsHub Logo
Followers 480
Posts 60380
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Monday, 02/27/2017 8:52:46 AM

Monday, February 27, 2017 8:52:46 AM

Post# of 5069
More Strange:


BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Ladenburg Thalmann Initiates Coverage On BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s stock to Buy with the price target of $11. This rating was issued on 2/16/17. The stock recently closed its previous session at $5.49 by showing a percentage change of -1.96% from its previous day closing price of $5.6.

Price Target is basically a projection of future price of a company’s stock by the expert analysis of investment analysts or investment firms. There may be various price targets for a stock. These analysts and investment firms use various valuation methods to decide a price target for a stock.

more...



http://hugopress.com/2017/02/27/featured-stock-for-investors-biocryst-pharmaceuticals-inc-nasdaqbcrx/



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BCRX News